Shi, M., Luo, J., Ding, L
This divergence suggests that the protective effects identified in the pathway analysis may involve mechanisms beyond genetic proxies, such as metabolic conditions (e.g., insulin resistance, inflammation), cellular states (e.g., energy stress, mitochondrial function), and environmental factors (e.g., antiviral effects, microbiota composition changes)
SGLT2 inhibitors (such as dapagliflozin or empagliflozin) offer complementary mechanisms with additional cardiovascular and renal protection benefits
Served with classic Caesar dressing
This blend has been investigated in hormonal rhythm research, growth hormone axis signaling studies, and experimental models examining endocrine pathway modulation and metabolic signaling interactions